Journal
CHEST
Volume 132, Issue 5, Pages 1447-1454Publisher
ELSEVIER SCIENCE BV
DOI: 10.1378/chest.07-0864
Keywords
acute lung injury; cytokines; pulmonary surfactant; pneumonia; Sftpd(-/-) mice
Categories
Funding
- NHLBI NIH HHS [HL58795, HL63329] Funding Source: Medline
Ask authors/readers for more resources
Background: Acute lung injury is a common cause of morbidity and mortality following pulmonary or systemic infections. Surfactant protein-D is a member of the collectin family of proteins, which play important roles in innate host defense of the lung. in this study, the effect of exogenous recombinant human SP-D (rhSP-D) on protection of the adult mouse lung from lipopolysaccharide (LPS)-induced and lipoteichoic acid (LTA)-induced injury was assessed. Methods: The effect of rhSP-D on LPS-induced and LTA-induced lung inflammation and injury was assessed with and without exogenous pulmonary surfactant in Sftpd(+/+) and Sftpd(-/-) mice. A total of 204 mice (6 mice per group) were used for the present study. Results: Sftpd(-/-) rnice were more susceptible to intratracheal LPS than were Sftpd(+/+) mice. rhSP-D decreased neutrophilic infiltrates induced by LPS and LTA in the lungs of both Sftpd(+/+) and Sftpd(-/-) mice. The addition of exogenous pulmonary surfactant to rhSP-D further decreased LPS-induced and LTA-induced pulmonary inflammation in Sftpd(-/-) and Sftpd(+/+) mice. Conclusions: Intratracheal rhSP-D inhibited inflammation induced by intratracheal LPS and LTA instillation in the lung. The antiinflammatory effects of rhSP-D were enhanced by the addition of pulmonary surfactant, providing a potential therapy for the treatment of lung inflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available